STTK Shattuck Labs Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: STTK

Price (delayed)

$10.78

Market cap

$512.6M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.93

Enterprise value

$439.79M

Shattuck Labs, Inc. operates as a clinical-stage biotechnology company . The Company focuses on developing a novel class of biologic medicines for the treatment of cancer and autoimmune diseases. Shattuck ...

Highlights
Shattuck Labs's gross profit has surged by 64% QoQ
STTK's revenue has surged by 64% since the previous quarter
STTK's quick ratio is down by 30% QoQ and by 5% YoY
The company's equity fell by 18% YoY and by 11% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.shattucklabs.com
Peers: DLB

Key stats

What are the main financial stats of STTK
Market
Shares outstanding
47.55M
Market cap
$512.6M
Enterprise value
$439.79M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.97
Price to sales (P/S)
200.78
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
161.98
Earnings
Revenue
$2.72M
EBIT
-$85.08M
EBITDA
-$80.7M
Free cash flow
-$71.26M
Per share
EPS
-$1.93
Free cash flow per share
-$1.41
Book value per share
$2.71
Revenue per share
$0.05
TBVPS
$2.89
Balance sheet
Total assets
$146.34M
Total liabilities
$17.52M
Debt
$3.19M
Equity
$128.81M
Working capital
$116.75M
Liquidity
Debt to equity
0.02
Current ratio
9.15
Quick ratio
8
Net debt/EBITDA
0.9
Margins
EBITDA margin
-2,972.2%
Gross margin
100%
Net margin
-3,133.6%
Operating margin
-3,327.4%
Efficiency
Return on assets
-57.5%
Return on equity
-64.9%
Return on invested capital
-142.6%
Return on capital employed
-64.5%
Return on sales
-3,133.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

STTK stock price

How has the Shattuck Labs stock price performed over time
Intraday
-2.88%
1 week
1.79%
1 month
22.78%
1 year
285%
YTD
51.19%
QTD
20.58%

Financial performance

How have Shattuck Labs's revenue and profit performed over time
Revenue
$2.72M
Gross profit
$2.72M
Operating income
-$90.34M
Net income
-$85.08M
Gross margin
100%
Net margin
-3,133.6%
STTK's operating margin has surged by 77% year-on-year and by 40% since the previous quarter
The net margin has surged by 77% year-on-year and by 41% since the previous quarter
Shattuck Labs's gross profit has surged by 64% QoQ
STTK's revenue has surged by 64% since the previous quarter

Growth

What is Shattuck Labs's growth rate over time

Valuation

What is Shattuck Labs stock price valuation
P/E
N/A
P/B
3.97
P/S
200.78
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
161.98
Shattuck Labs's EPS has increased by 17% YoY and by 6% from the previous quarter
The stock's price to book (P/B) is 134% more than its last 4 quarters average of 1.7
The company's equity fell by 18% YoY and by 11% QoQ
STTK's revenue has surged by 64% since the previous quarter
STTK's price to sales (P/S) is 45% higher than its last 4 quarters average of 138.1

Efficiency

How efficient is Shattuck Labs business performance
The ROIC has shrunk by 118% YoY and by 14% QoQ
Shattuck Labs's ROS has soared by 77% YoY and by 41% from the previous quarter
STTK's return on assets is down by 26% year-on-year and by 2.5% since the previous quarter
The ROE has declined by 25% year-on-year and by 2.9% since the previous quarter

Dividends

What is STTK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for STTK.

Financial health

How did Shattuck Labs financials performed over time
STTK's quick ratio is down by 30% QoQ and by 5% YoY
STTK's current ratio is down by 27% since the previous quarter and by 7% year-on-year
The debt is 98% smaller than the equity
The company's debt to equity fell by 33% YoY
The debt has declined by 20% year-on-year and by 6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.